Skip to main content

US ClosedU.S. Closed

VRDN: Viridian Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses.

52W Range

47thpctl

Volume

0.33×avg

Market Cap

2.61BUSD

P/E Ratio

-6.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Viridian Therapeutics, Inc.

VRDNNASDAQ Capital Market·USD·Closed

Viridian Therapeutics, Inc.

VRDNNASDAQ·USD·Closed

$23.08

−3.35%

$23.08

−$0.80 (3.35%)

52W Range

47thpctl

Volume

0.33×avg

Mkt Cap

2.61BUSD

P/E

-6.5TTM

Div Yield

–ann